SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000947871-16-001513
Filing Date
2016-09-26
Accepted
2016-09-26 16:08:11
Documents
2
Group Members
ORBIMED CAPITAL GP III LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 ss11900_sc13da.htm SC 13D/A 202539
2 JOINT FILING AGREEMENT ss11900_ex9901.htm EX-99.1 20576
  Complete submission text file 0000947871-16-001513.txt   224760
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address IM NEUENHEIMER FELD 582, 69120 HEIDELBERG 2M 000000
Business Address IM NEUENHEIMER FELD 582, 69120 HEIDELBERG 2M 000000 49-6221-65307
Affimed N.V. (Subject) CIK: 0001608390 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88320 | Film No.: 161902364
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences